![](/img/cover-not-exists.png)
Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas
Crittenden, Marka, Bahjat, Keith S, Li, Rui, Gore, Pankaj, Fountain, Chris, Hanson, Bill, Skoble, Justin, Lauer, Peter, Murphy, Aimee L, Dubensky, Thomas, Brockstedt, Dirk G, Urba, WalterVolume:
3
Year:
2015
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/2051-1426-3-S2-P162
File:
PDF, 254 KB
english, 2015